Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
A phase 2 randomized controlled trial of personalized peptide vaccine immunotherapy with low-dose dexamethasone versus dexamethasone alone in chemotherapy-naive castration-resistant prostate cancer
What BPC-157 Actually Does Before You See Any Results BPC-157, short for Body Protective Compound 157, is a synthetic peptide derived from a naturally occurring protein fragment found in human gastric juice
One is by up-regulating a signaling protein called VEGF (vascular endothelial growth factor), which encourages the growth of new capillaries
Research suggests that tirzepatide causes a 40% reduction in visceral fat mass and a 7-inch reduction in waist circumference after 72 weeks
As regulators, providers, and patients navigate these developments, Empower continues to be a leading voice helping shape the conversation around peptide therapy, quality standards, and regulatory policy
